Kidney & Urology Foundation of America
Kidney & Urology Foundation of America
SAVE THE DATE:
Support Walk the Walk
New York Walk the Walk

October 31, 2010 - Central Park
REGISTER ONLINE NOW!
join us on Facebook
Join KUFA today
and become an essential part of the fight to save and improve lives. There are no fees for patients, family and friends to get connected!

 

Patient Resources


Therapeutic Areas: Oncology | Family Medicine

Adenocarcinoma Clinical Trials


A listing of Adenocarcinoma medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

Alabama

Birmingham : University of Alabama at Birmingham

A clinical trial to evaluate treatments using live-attenuated Listeria monocytogenes cancer vaccine ADXS11-001 and laboratory biomarker analysis for patients with Cervical Cancer

Huntsville : Clearview Cancer Institute

Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer

Arizona

Phoenix : Saint Joseph's Hospital and Medical Center

A clinical trial to evaluate treatments using live-attenuated Listeria monocytogenes cancer vaccine ADXS11-001 and laboratory biomarker analysis for patients with Cervical Cancer

Scottsdale : Scottsdale Healthcare

A clinical research study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody for the treatment of Malignant Solid Tumors

Scottsdale : Research Site

A clinical trial seeking patients for a research study for the treatment of Renal Cell Adenocarcinoma, Clear Cell Renal Carcinoma, Clear Cell Renal Cell Carcinoma or Renal Cell Carcinoma

Scottsdale : Translational Genomics Research Institute (TGen)

A clinical trial seeking patients for a research study for the treatment of Solid Tumors

Scottsdale : Mayo Clinic Arizona

A Phase 1 clinical study for patients with Advanced Pancreatic Cancer, Metastatic Pancreatic Cancer or Pancreatic Adenocarcinoma

Scottsdale : Mayo Clinic Arizona - Cancer Clinical Research Unit

Patients are needed to participate in a clinical research study evaluating CDX-1127

Scottsdale :

Patients are needed to participate in a clinical research study evaluating Ferumoxytol followed by MM-398

Tucson : University of Arizona Health Sciences Center

A clinical research study for the treatment of Metastatic Pancreatic Adenocarcinoma

Tucson : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Tucson : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Arkansas

Hot Springs : Genesis Cancer Center Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

California

Duarte : City of Hope, Site #009

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Duarte : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Hollywood : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

La Jolla : Moores Cancer Center University of California, San Diego, Site #099

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

La Jolla : UC San Diego Moores Cancer Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Los Angeles : Cedars Sinai Medical Center

A clinical research study of CEP-37250/KHK2804 for the treatment of Solid Tumour, Adenocarcinoma of the Colorectal or Adenocarcinoma of the Pancreas

Los Angeles : Cedars Sinai Medical Center SC

A clinical research study of LDE225 and BKM120

Los Angeles : Cedars Sinai Medical Center Updated

A clinical trial seeking patients for a research study for the treatment of Pancreatic Cancer or Pancreatic Ductal Adenocarcinoma

Los Angeles : USC Norris Comprehensive Cancer Center

A Phase 1 clinical study for patients with Advanced Pancreatic Cancer, Metastatic Pancreatic Cancer or Pancreatic Adenocarcinoma

Los Angeles : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Los Angeles : USC Norris Comprehensive Cancer Center

Patients are needed to participate in a clinical research study evaluating orteronel and laboratory biomarker analysis for the treatment of Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Pasadena : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Sacramento : UC Davis Comprehensive Cancer Center

Alisertib and Gemcitabine Hydrochloride in Treating Patients With Solid Tumors or Pancreatic Cancer

Sacramento : UC Davis Comprehensive Cancer Center

Irinotecan and Alisertib in Treating Patients With Advanced Solid Tumors or Colorectal Cancer

Sacramento : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

San Diego : Kaiser Permanente, Site #208

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

San Francisco : University of California San Francisco UCSF (SC)

A clinical research study of LDE225 and BKM120

San Francisco : UCSF-Mount Zion

A clinical trial to evaluate treatments using live-attenuated Listeria monocytogenes cancer vaccine ADXS11-001 and laboratory biomarker analysis for patients with Cervical Cancer

San Francisco : UCSF - Mount Zion

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Santa Monica : University of California, Los Angeles Medical Center (UCLA)

A clinical trial seeking patients for a research study for the treatment of Solid Tumors

Stanford : Stanford Cancer Center - Stanford University

Patients are needed to participate in a clinical research study evaluating CDX-1127

Whittier :

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Whittier : Innovative Clinical Research Institute

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Colorado

Aurora : University of Colorado Cancer Center Updated

A clinical research study of Ponatinib

Aurora : University of Colorado Cancer Center, Site #015

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Aurora : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Aurora : University of Colorado Anschutz Medical Campus

Patients are needed to participate in a clinical research study of IMMU-132

Denver : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Edwards : The Shaw Regional Cancer Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Connecticut

Farmington : University of Connecticut Health Center

A Phase 2 clinical study for patients with Ovarian Neoplasms

Hartford : Saint Francis Hospital and Medical Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Delaware

Newark : Helen F. Graham Cancer Center

Patients are needed to participate in a clinical research study of IMMU-132

District of Columbia

Washington : Research Site

A clinical research study of MEDI-565 for the treatment of Gastrointestinal Adenocarcinomas

Florida

Boca Raton : Lynn Cancer Institute

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Boca Raton : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Deerfield Beach : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Fort Myers : Florida Cancer Specialists - South Updated

A clinical trial to evaluate treatments using 5-Fluorouracil, Oxaliplatin, Lapatinib and Radiation Therapy for patients with Localized HER2 Positive Esophagogastric Cancer

Fort Myers : Florida Cancer Specialists

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Gainesville : University of Florida

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Jacksonville :

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Jacksonville : Mayo Clinic Jacksonville

A clinical research study of Tumor markers for the treatment of Pancreatic Adenocarcinoma

Jacksonville : Mayo Clinic Florida

Patients are needed to participate in a clinical research study of Spectroscopy device to evaluate Pancreatic Adenocarcinoma

Miami :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Miami Beach : Mount Sinai Medical Center CCOP

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Orlando : Florida Hospital Cancer Institute Updated

A clinical trial to evaluate treatments using 5-Fluorouracil, Oxaliplatin, Lapatinib and Radiation Therapy for patients with Localized HER2 Positive Esophagogastric Cancer

Orlando : Florida Hospital Cancer Institute Memorial System

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Orlando : MD Anderson Cancer Center Orlando

Patients are needed to participate in a clinical research study of IMMU-132

Pembroke Pines : Memorial Cancer Institute

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

Pensacola : Woodlands Medical Specialists Updated

A clinical trial to evaluate treatments using 5-Fluorouracil, Oxaliplatin, Lapatinib and Radiation Therapy for patients with Localized HER2 Positive Esophagogastric Cancer

Pensacola : Sacred Heart Medical Oncology Group - Davis Highway

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Pensacola : Sacred Heart Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Sarasota : Florida Cancer Specialists / Sarah Cannon Research Institute

A clinical research study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody for the treatment of Malignant Solid Tumors

St. Petersburg : Florida Cancer Specialists-North Updated

A clinical trial to evaluate treatments using 5-Fluorouracil, Oxaliplatin, Lapatinib and Radiation Therapy for patients with Localized HER2 Positive Esophagogastric Cancer

St. Petersburg : Florida Cancer Specialists

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Tampa : H. Lee Moffitt Cancer Center & Research Institute Moffitt 4

A clinical research study of LDE225 and BKM120

Tampa : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Tampa : Moffitt Cancer Center

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Georgia

Savannah : Memorial University Medical Center

RTOG 1010: A Phase III Trial Evaluating the Addition of Trastuzumab to Trimodality Treatment of HER2-Overexpressing Esophageal Adenocarcinoma

Atlanta : Emory University

A clinical research study of CEP-37250/KHK2804 for the treatment of Solid Tumour, Adenocarcinoma of the Colorectal or Adenocarcinoma of the Pancreas

Atlanta : Piedmont Hospital Research Institute

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

Atlanta : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Augusta : Research Site

A clinical research study of MEDI-565 for the treatment of Gastrointestinal Adenocarcinomas

Gainesville : Northeast Georgia Medical Center Updated

A clinical trial to evaluate treatments using 5-Fluorouracil, Oxaliplatin, Lapatinib and Radiation Therapy for patients with Localized HER2 Positive Esophagogastric Cancer

Marietta :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Savannah : Memorial Health University Medical Center

A clinical trial to evaluate treatments using live-attenuated Listeria monocytogenes cancer vaccine ADXS11-001 and laboratory biomarker analysis for patients with Cervical Cancer

Illinois

Arlington Heights : Illinois Cancer Specialists

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Arlington Heights :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Chicago : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Chicago : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Evanston : Northshore University Healthsystem Research Institute

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Peoria : Illinois Cancer Care - Peoria

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Quincy : Quincy Medical Group - Clinic

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Indiana

Goshen : Indiana University Health Goshen Center for Cancer Care

A Phase 2 clinical study for patients with Metastatic Pancreatic Ductal Adenocarcinoma

Goshen : IU Health Goshen Cancer Center

Patients are needed to participate in a clinical research study of IMMU-132

Indianapolis : IU Simon Cancer Center

Patients are needed to participate in a clinical research study evaluating porfimer sodium, endoscopic ultrasonography, photodynamic therapy and gemcitabine hydrochloride for the treatment of Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas or Stage III Pancreatic Cancer

Lafayette :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Mishawaka : Michiana Hematology Oncology PC-Mishawaka

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

South Bend : Northern Indiana Cancer Research Consortium

A Phase 2 clinical study for patients with Ovarian Neoplasms

Terre Haute : RHHP/Hope Center

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Westville : Michiana Hematology Oncology-PC Westville

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Iowa

Bettendorf : Hematology Oncology Associates - Quad Cities

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Davenport : Genesis Medical Center - East Campus

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Iowa City : VA Medical Center - University of Iowa

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Iowa City : University of Iowa Hospitals and Clinics

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Kansas

Topeka :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Kentucky

Ashland :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Paducah : Western Kentucky Hematology and Oncology Group Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Louisiana

Marrero : Crescent City Research Consortium

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Maine

Augusta : Harold Alfond Center for Cancer Care

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Bangor : Eastern Maine Medical Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Maryland

Baltimore : Johns Hopkins University-Sidney Kimmel Cancer Center

A clinical trial to evaluate treatments using live-attenuated Listeria monocytogenes cancer vaccine ADXS11-001 and laboratory biomarker analysis for patients with Cervical Cancer

Baltimore : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Baltimore : Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

A Phase 1/Phase 2 clinical study for patients with Resectable Pancreatic Adenocarcinoma

Baltimore : Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

A Phase 2 clinical study for patients with Metastatic Pancreatic Cancer

Bethesda : Center for Cancer and Blood Disorders

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Easton : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Frederick : Frederick Memorial Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Massachusetts

Boston : Dana Farber Cancer Institute Dana SC

A clinical research study of LDE225 and BKM120

Boston : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Boston : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Boston : Massachusettes General Hospital

Patients are needed to participate in a clinical research study of IMMU-132

Rockland : Please Contact U.S. Medical Information Located in

A clinical trial seeking patients for a research study for the treatment of Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma

Michigan

Ann Arbor : University of Michigan University Hospital

A clinical trial to evaluate treatments using live-attenuated Listeria monocytogenes cancer vaccine ADXS11-001 and laboratory biomarker analysis for patients with Cervical Cancer

Ann Arbor : University of Michigan

Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer

Ann Arbor : Saint Joseph Mercy Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Detroit : Wayne State University/Karmanos Cancer Institute Wayne St

A Phase 1 clinical study for patients using LGK974

Detroit : Karmanos Cancer Institute

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Detroit : Henry Ford Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Escanaba : Green Bay Oncology - Escanaba

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Grand Rapids : Grand Rapids Oncology Program Updated

A clinical trial to evaluate treatments using 5-Fluorouracil, Oxaliplatin, Lapatinib and Radiation Therapy for patients with Localized HER2 Positive Esophagogastric Cancer

Iron Mountain : Green Bay Oncology - Iron Mountain

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Livonia : Saint Mary Mercy Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Saginaw : Saint Mary's of Michigan

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Minnesota

Coon Rapids : Mercy Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Duluth : Essentia Health Duluth Clinic CCOP

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Rochester : Mayo Clinic - Rochester Division of Hematology

A clinical research study of LDE225 and BKM120

Rochester : Mayo Clinic

A Phase 1 clinical study for patients with Advanced Pancreatic Cancer, Metastatic Pancreatic Cancer or Pancreatic Adenocarcinoma

Rochester : Mayo Clinic

Patients are needed to participate in a clinical research study evaluating CDX-1127

Shakopee : Saint Francis Regional Medical Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

St. Louis Park : Park Nicollet Cancer Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Stillwater : Lakeview Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Woodbury : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Woodbury :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Missouri

Cape Girardeau : Saint Francis Medical Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Chesterfield : Saint Luke's Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Columbia : University of Missouri - Ellis Fischel

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Jefferson City :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Springfield : Mercy Hospital - Springfield

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

St. Louis : Research Site

A clinical trial seeking patients for a research study for the treatment of Renal Cell Adenocarcinoma, Clear Cell Renal Carcinoma, Clear Cell Renal Cell Carcinoma or Renal Cell Carcinoma

St. Louis : Washington University School of Medicine

A clinical trial to evaluate treatments using live-attenuated Listeria monocytogenes cancer vaccine ADXS11-001 and laboratory biomarker analysis for patients with Cervical Cancer

St. Louis : Washington University School of Medicine

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

St. Louis : Missouri Baptist Medical Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Montana

Billings : Saint Vincent Healthcare

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Bozeman : Bozeman Deaconess Cancer Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Nebraska

Omaha : Nebraska Cancer Specialists, Methodist Estabrook Cancer Center

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

Omaha : UNMC Eppley Cancer Center at the University of Nebraska Medical Center

A clinical trial seeking patients for a research study of ADH-1, cisplatin, gemcitabine hydrochloride and laboratory biomarker analysis

Omaha : Nebraska Methodist Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Omaha :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Nevada

Henderson : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Las Vegas : HealthCare Partners Medical Group Oncology/Hematology-San Martin

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Las Vegas : HealthCare Partners Medical Group Oncology/Hematology-Tenaya

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Las Vegas :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

New Hampshire

Concord : New Hampshire Oncology - Hematology PA

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Dover : Wentworth Douglass Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Hooksett : New Hampshire Oncology Hematology Associates

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Laconia : LRGHealthcare-Lakes Region General Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Lebanon : Dartmouth-Hitchcock Norris Cotton Cancer Center

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

New Jersey

Basking Ridge : Memoral Sloan Kettering Cancer Center

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

Basking Ridge : Memorial Sloan-Kettering Cancer Center at Basking Ridge

A clinical trial to evaluate treatments using Regorafenib for patients with Metastatic Colorectal Adenocarcinoma

Basking Ridge : Memoral Sloan Kettering Cancer Center

A Phase 1/Phase 2 clinical study for patients with Lung Cancer

Basking Ridge : Memoral Sloan Kettering Cancer Center

A Phase 2 clinical study for patients with Esophageal Adenocarcinoma

Morristown : Regional Cancer Care Associates/ Carol G. Simon Cancer Center Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

New Mexico

Albuquerque : University of New Mexico

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Las Cruces : Memorial Medical Center-Las Cruces

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Santa Fe : Christus Saint Vincent Regional Cancer Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

New York

Brooklyn : Maimonides Medical Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Buffalo : Roswell Park Cancer Institute Updated

A clinical trial seeking patients for a research study for the treatment of Adenocarcinoma of the Pancreas, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer or Unspecified Adult Solid Tumor, Protocol Specific

Buffalo : Roswell Park Cancer Institute

A clinical trial to evaluate treatments using vorinostat, temsirolimus, laboratory biomarker analysis and positron emission tomography/computed tomography for patients

Buffalo : Roswell Park Cancer Institute

Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer

Commack : Memorial Sloan-Kettering Cancer Center @ Suffolk

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

Commack : Memorial Sloan-Kettering Cancer Center at Commack

A clinical trial to evaluate treatments using Regorafenib for patients with Metastatic Colorectal Adenocarcinoma

Commack : Memorial Sloan Kettering Cancer Center @ Suffolk

A Phase 1/Phase 2 clinical study for patients with Lung Cancer

Hudson :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Jamaica : Queens Cancer Center of Queens Hospital

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

New Hyde Park : Long Island Jewish Medical Center

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

New York : Weill Cornell Medical College

A clinical trial seeking patients for a research study for the treatment of Gastric Adenocarcinoma, Gastroesophageal Adenocarcinoma or Distal Esophageal Adenocarcinoma

New York : Memorial Sloan-Kettering Cancer Center 1275 York Avenue

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

New York : Weill Cornell Medical College

A clinical trial seeking patients for a research study for the treatment of Small Cell Prostate Cancer, Neuroendocrine Prostate Cancer or Prostate Adenocarcinoma Plus > 50% Immunohistochemical Staining for Neuroendocrine Markers

New York : Memorial Sloan Kettering Cancer Center Updated

A clinical trial to evaluate treatments using degarelix injection and androgen deprivation therapy for patients with Prostate Cancer or Prostatic Adenocarcinoma

New York : Memorial Sloan-Kettering Cancer Center

A clinical trial to evaluate treatments using Regorafenib for patients with Metastatic Colorectal Adenocarcinoma

New York : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

New York : Memorial Sloan Kettering Cancer Center

A Phase 1/Phase 2 clinical study for patients with Lung Cancer

New York : Memorial Sloan Kettering Cancer Center

A Phase 2 clinical study for patients with Esophageal Adenocarcinoma

New York : Columbia University Medical Center

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

New York : Icahn School of Medicine at Mount Sinai Hess Center for Science and Medicine

Patients are needed to participate in a clinical research study evaluating CDX-1127

New York : Memorial Sloan-Kettering Cancer Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

New York : Weill Cornell/New York Presbyterian Hospital

Patients are needed to participate in a clinical research study of IMMU-132

Rochester : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Rochester : University of Rochester Medical Center

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Rockville Centre : Memorial Sloan-Kettering at Mercy Medical Center

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

Rockville Centre : Memorial Sloan-Kettering Cancer Center at Mercy Medical Center

A clinical trial to evaluate treatments using Regorafenib for patients with Metastatic Colorectal Adenocarcinoma

Rockville Centre : Memorial Sloan Kettering at Mercy Medical Center

A Phase 1/Phase 2 clinical study for patients with Lung Cancer

Sleepy Hollow : Memoral Sloan Kettering Cancer Center@Phelps Memorial Hospital

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

Sleepy Hollow : Memorial Sloan-Kettering Cancer Center Sleepy Hollow

A clinical trial to evaluate treatments using Regorafenib for patients with Metastatic Colorectal Adenocarcinoma

Sleepy Hollow : Memoral Sloan Kettering Cancer Center at Phelps

A Phase 1/Phase 2 clinical study for patients with Lung Cancer

North Carolina

Asheboro : Randolph Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Chapel Hill : University of North Carolina at Chapel Hill

A clinical study for patients with Barrett's Esophagus, Intestinal Metaplasia or Intramucosal Adenocarcinoma

Chapel Hill : UNC - Chapel Hill

A clinical research study of CEP-37250/KHK2804 for the treatment of Solid Tumour, Adenocarcinoma of the Colorectal or Adenocarcinoma of the Pancreas

Chapel Hill : University of North Carolina

Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer

Chapel Hill : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Charlotte : Carolinas Medical Center

A clinical trial to evaluate treatments using live-attenuated Listeria monocytogenes cancer vaccine ADXS11-001 and laboratory biomarker analysis for patients with Cervical Cancer

Charlotte : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Durham : Duke University Medical Center Duke - Baker

A clinical research study of LDE225 and BKM120

Durham : Research Site

A clinical research study of MEDI-565 for the treatment of Gastrointestinal Adenocarcinomas

Greensboro : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Greensboro : Core Health Cancer Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Reidsville : Annie Penn Memorial Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Washington : Marion L. Shepard Cancer Center at Beaufort County Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Winston-Salem : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Winston-Salem : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

North Dakota

Bismarck : Sanford Bismarck Medical Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Fargo : Sanford Medical Center-Fargo

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Fargo : Sanford Clinic North-Fargo

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Ohio

Canton :

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Canton :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Canton : Gabrail Cancer Center Research

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Cincinnati : Oncology Hematology Care Updated

A clinical trial to evaluate treatments using 5-Fluorouracil, Oxaliplatin, Lapatinib and Radiation Therapy for patients with Localized HER2 Positive Esophagogastric Cancer

Cincinnati : Oncology Hematology Care Inc.

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Cleveland : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Cleveland : Case Western Reserve University

A clinical trial to evaluate treatments using live-attenuated Listeria monocytogenes cancer vaccine ADXS11-001 and laboratory biomarker analysis for patients with Cervical Cancer

Cleveland : Case Western Reserve University

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Cleveland : Cleveland Clinic Foundation

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Columbus : The Ohio State University

A clinical research study of CEP-37250/KHK2804 for the treatment of Solid Tumour, Adenocarcinoma of the Colorectal or Adenocarcinoma of the Pancreas

Columbus : Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center

A clinical trial to evaluate treatments using panitumumab, irinotecan hydrochloride, fluorouracil and leucovorin calcium for patients

Columbus : Ohio State University Comprehensive Cancer Center

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Columbus : Ohio State University Medical Center

Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer

Columbus : The Ohio State University Comprehensive Cancer Center

Patients are needed to participate in a clinical research study evaluating CDX-1127

Mentor : Lake University Ireland Cancer Center

A clinical trial to evaluate treatments using live-attenuated Listeria monocytogenes cancer vaccine ADXS11-001 and laboratory biomarker analysis for patients with Cervical Cancer

Oklahoma

Lawton : Cancer Centers of Southwest Oklahoma, LLC - Lawton

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Oklahoma City : University of Oklahoma Health Sciences Center

A clinical trial to evaluate treatments using live-attenuated Listeria monocytogenes cancer vaccine ADXS11-001 and laboratory biomarker analysis for patients with Cervical Cancer

Oklahoma City : University of Oklahoma Health Sciences Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Oregon

Corvallis : Good Samaritan Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Eugene : Willamette Valley Clinical Studies Williamette Valley Cancer

A clinical research study of LDE225 and BKM120

Eugene :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Portland : Northwest Cancer Specialists Main Site

A clinical research study of LDE225 and BKM120

Portland : Oregon Health and Sciences University

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Portland : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Portland : Oregon Health and Science University

Patients are needed to participate in a clinical research study evaluating CDX-1127

Portland : Kaiser Permanente Health Care - Portland

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Portland :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Pennsylvania

Gettysburg : Adams Cancer Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Philadelphia : Fox Chase Cancer Center FCCC

A clinical research study of LDE225 and BKM120

Philadelphia : Research Site

A clinical research study of MEDI-565 for the treatment of Gastrointestinal Adenocarcinomas

Philadelphia : University of Pennsylvania Updated

A clinical trial seeking patients for a research study for the treatment of Pancreatic Cancer or Pancreatic Ductal Adenocarcinoma

Philadelphia : University of Pennsylvania

A Phase 2 clinical study for patients with Metastatic Pancreatic Cancer

Philadelphia : Thomas Jefferson University

Patients are needed to participate in a clinical research study evaluating Cabazitaxel, Intensity Modulated Radiation Therapy (IMRT), Anti-Androgen Therapy: Bicalutamide and Luteinizing Hormone-Releasing Hormone (LHRH) Agonist for the treatment of Prostate Cancer

Philadelphia : Thomas Jefferson University

Patients are needed to participate in a clinical research study of Alisertib, Abiraterone acetate and Prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Philadelphia : Thomas Jefferson University

Patients are needed to participate in a clinical research study of Enzalutamide, Goserelin acetate, Leuprolide acetate and Radiation therapy

Pittsburgh : University of Pittsburgh Cancer Institute

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

Pittsburgh : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Pittsburgh : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

York : WellSpan Health-York Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

South Carolina

Charleston :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Charleston : Medical Universtiy of South Carolina (MUSC)

A clinical trial seeking patients for a research study for the treatment of Solid Tumors

South Dakota

Sioux Falls : Sanford Cancer Center Oncology Clinic

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Watertown : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Tennessee

Chattanooga : Chattanooga Oncology and Hematology Associates Updated

A clinical trial to evaluate treatments using 5-Fluorouracil, Oxaliplatin, Lapatinib and Radiation Therapy for patients with Localized HER2 Positive Esophagogastric Cancer

Chattanooga : Tennessee Oncology - Chattanooga

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Knoxville :

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Nashville : Tennessee Oncology

A clinical research study of MORAb-066

Nashville :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Nashville : Tennessee Oncology Updated

A clinical trial to evaluate treatments using 5-Fluorouracil, Oxaliplatin, Lapatinib and Radiation Therapy for patients with Localized HER2 Positive Esophagogastric Cancer

Nashville : Tennessee Oncology PLLC

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Nashville : Sarah Cannon Research Institute

Patients are needed to participate in a clinical research study evaluating CDX-1127

Texas

Arlington :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Beaumont :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Bedford : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Bedford :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Dallas : Mary Crowley Cancer Center

A clinical research study of CEP-37250/KHK2804 for the treatment of Solid Tumour, Adenocarcinoma of the Colorectal or Adenocarcinoma of the Pancreas

Dallas : Texas Oncology, P.A. SC

A clinical research study of LDE225 and BKM120

Dallas : Sammons Cancer Center - Texas Oncology SC-2

A clinical research study of LDE225 and BKM120

Dallas : University of Texas Southwestern Medical Center

A clinical trial to evaluate treatments using live-attenuated Listeria monocytogenes cancer vaccine ADXS11-001 and laboratory biomarker analysis for patients with Cervical Cancer

Dallas : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Dallas : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Dallas : Mary Crowley Cancer Research Centers - Medical City

Patients are needed to participate in a clinical research study evaluating CDX-1127

Dallas :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Denton :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Fort Worth : Center for Cancer and Blood Disorders

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Galveston : University of Texas Medical Branch at Galveston

A clinical trial to evaluate treatments using live-attenuated Listeria monocytogenes cancer vaccine ADXS11-001 and laboratory biomarker analysis for patients with Cervical Cancer

Houston : UT MD Anderson Cancer Center

A clinical research study of Abraxane for the treatment of Colorectal Cancer or Cancer of Gastrointestinal Tract

Houston : Department of Investigator Cancer Therapeutics, University of Texas, MD Anderson Cancer Center

A clinical research study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody for the treatment of Malignant Solid Tumors

Houston : University of Texas/MD Anderson Cancer Center SC-3

A clinical research study of LDE225 and BKM120

Houston : MD Anderson Cancer Center Updated

A clinical trial seeking patients for a research study for the treatment of Pancreatic Cancer or Pancreatic Ductal Adenocarcinoma

Houston : University of Texas/MD Anderson Cancer Center MD Anderson 2

A Phase 1 clinical study for patients using LGK974

Houston : UT MD Anderson Cancer Center

A Phase 2 clinical study for patients with Gastrointestinal Cancer

Houston : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Houston : UT MD Anderson Cancer Center

Patients are needed to participate in a clinical research study evaluating Capecitabine, Oxaliplatin and Bevacizumab for the treatment of Gastrointestinal Cancers

Houston : M.D. Anderson Cancer Center

Patients are needed to participate in a clinical research study of selinexor to evaluate Prostate Cancer

Houston : The University of Texas M. D. Anderson Cancer Center

Patients are needed to participate in a clinical research study of Spectroscopy device to evaluate Pancreatic Adenocarcinoma

Plano :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Round Rock :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

San Antonio : Cancer Therapy and Research Center (CTRC), The University of Texas Health Science Center at San Antonio

A clinical research study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody for the treatment of Malignant Solid Tumors

San Antonio : Novartis Investigative Site

A Phase 2 clinical study for patients with Cachexia

Utah

Salt Lake City : University of Utah / Huntsman Cancer Institute Huntsman

A clinical research study of LDE225 and BKM120

Virginia

Richmond : Virginia Commonwealth University

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Washington

Bellingham : PeaceHealth Saint Joseph Medical Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Poulsbo : Harrison Health Partners Hematology and Oncology - Poulsbo

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Seattle : Swedish Medical Center Cancer Institute

A clinical research study of AUY922 and Cetuximab

Seattle : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Seattle : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Seattle : Virginia Mason Cancer Center

Patients are needed to participate in a clinical research study of IMMU-132

Tacoma : Northwest Medical Specialties

A Phase 2 clinical study for patients with Metastatic Pancreatic Ductal Adenocarcinoma

Tacoma : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

West Virginia

Huntington : Saint Mary's Medical Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Wisconsin

Green Bay : Saint Mary's Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Green Bay : Saint Vincent Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Green Bay : Green Bay Oncology at Saint Vincent Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Manitowoc : Holy Family Memorial Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Marshfield : Saint Joseph's Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Marshfield : Marshfield Clinic

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Milwaukee : Medical College of Wisconsin

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

Oconto Falls : Green Bay Oncology - Oconto Falls

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Sheboygan : Saint Nicholas Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Stevens Point : Marshfield Clinic at Saint Michael's Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Stevens Point : Saint Michael's Hospital Cancer Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Sturgeon Bay : Green Bay Oncology - Sturgeon Bay

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Weston : Marshfield Clinic - Weston Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Weston : Diagnostic and Treatment Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Argentina

Ciudad Autonoma de Buenos Aires : Instituto de Oncologia Angel H. Roffo

A clinical research study of CIGB300 for the treatment of Squamous Cell Carcinoma of the Cervix or Adenocarcinoma of the Cervix

Australia

Bentleigh East : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Campbelltown : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Coffs Harbour : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Douglas : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Elizabeth Vale : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Heidelberg : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Heidelberg : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Kurralta Park : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Kurralta Park : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Murdoch : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Randwick : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Ringwood East : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

South Brisbane : Icon Cancer Care South Brisbane

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

St Leonards : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Tamworth : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Tweed Heads : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Tweed Heads : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Woolloongabba : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Austria

Graz : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Innsbruck : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Krems : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Kufstein : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Linz : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Linz : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Linz : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Salzburg : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Vienna : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Vienna : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Wels : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Wien : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Belgium

Brussels : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Brussels : Hôpital Erasme

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Brussels : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Brussels : Novartis Investigative Site

Patients are needed to participate in a clinical research study of RAD001

Bruxelles : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Bruxelles : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Bruxelles : Hôpital Erasme

Patients are needed to participate in a clinical research study of Spectroscopy device to evaluate Pancreatic Adenocarcinoma

Charleroi : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Charleroi : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Edegem : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Edegem : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Gent : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Gent : Novartis Investigative Site

Patients are needed to participate in a clinical research study of RAD001

Haine St. Paul : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Jette : AZ VUB

A Phase 2 clinical study for patients with Lung Neoplasms, Non-Small Cell Lung Cancer or Adenocarcinoma, Bronchiolo-Alveolar

Leuven : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Liege : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Liège : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Roeselare : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Wilrijk : Novartis Investigative Site

A clinical research study of LDE225 and BKM120

Yvoir : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Bosnia and Herzegovina

Banja Luka : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Banja Luka : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Sarajevo : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Sarajevo : Synta Pharmaceuticals Investigative Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Tuzla : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Brazil

Pelotas : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Santo Andre : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Sao Paulo : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Sao Paulo : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

São Paulo : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Bulgaria

Plovdiv : Multiprofile Hospital for Active Treatment "Central Onco Hospital", Plovdiv, Department of Medical Oncology

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Plovdiv : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Shumen : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Sofia : Military Medical Academy - Multiprofile Hospital for Active Treatment, Sofia, Department of Medical Oncology

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Sofia : Multiprofile Hospital for Active Treatment "Serdika", Sofia, Department of Medical Oncology

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Sofia : University Multiprofile Hospital for Active Treatment "Tsaritsa Yoanna - ISUL", Sofia, Clinic of Medical Oncology

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Sofia : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Sofia : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Sofia : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Sofia : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Varna : Multiprofile Hospital for Active Treatment "Sveta Marina", Varna, Clinic of Medical Oncology

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Varna : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Canada

Edmonton : Cross Cancer Institute

A clinical research study of Irinotecan-Capecitabine-Oxaliplatin for the treatment of Gastrointestinal Neoplasm or Gastric Adenocarcinoma

Edmonton : Novartis Investigative Site

A clinical research study of LDE225 and BKM120

Edmonton : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Greenfield Park : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Laval : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

London : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Montreal : Jewish General Hospital

A clinical research study of Androgen suppression plus radiation therapy for the treatment of Adenocarcinoma of the Prostate

Montreal : Montreal General Hospital

A clinical research study of Androgen suppression plus radiation therapy for the treatment of Adenocarcinoma of the Prostate

Montreal : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Montreal : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Toronto : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Toronto : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Vancouver : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

China

Beijing : Chinese People's Liberation Army (PLA) General Hospital

A clinical trial seeking patients for a research study for the treatment of EGFR Positive Non-small Cell Lung Cancer or Adenocarcinoma

Beijing : Cancer Insititute and Hospital,Chinese Academy of Medical Sciences

A clinical trial seeking patients for a research study for the treatment of Liver Cancer or Pancreatic Adenocarcinoma

Beijing : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Beijing : Cancer Hospital, Chinese Academy of Medical Sciences

A Phase 2 clinical study for patients with Adenocarcinoma of the Gastroesophageal Junction or Esophageal Carcinoma

Beijing : Peking Unicersity Cancer Hospital

A Phase 3 clinical study for patients with Advanced Gastric Carcinoma

Beijing : Department of GI Oncology, Peking University, School of Oncology

Patients are needed to participate in a clinical research study evaluating Paclitaxel, capecitabine and cisplatin for the treatment of Advanced Gastric Cancer

Beijing : Beijing Cancer Hospital

Patients are needed to participate in a clinical research study of SOX sequential S-1 to evaluate Biliary Tract Cancer, Periampullary Adenocarcinoma or Pancreatic Cancer

Changchun : The First Bethune Hospital of Jilin Univercity

A Phase 3 clinical study for patients with NSCLC

Changsha : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Changzhou : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Chengdu : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Chengdu : Sichuan Provincal Tumor Hospital

A Phase 3 clinical study for patients with NSCLC

Chengdu City : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Chongqing : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Foshan City : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Guangzhou : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Hangzhou : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Hangzhou City : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Harbin : Harbin Medical Univercity Cancer Hospital

A Phase 3 clinical study for patients with NSCLC

Nanjing : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Shanghai : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Shenyang : The First Hospital of China Medical University

A Phase 3 clinical study for patients with NSCLC

Shijiazhuang : Hebei Provincal Tumor Hospital

A Phase 3 clinical study for patients with NSCLC

Suzhou City : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Taiyuan : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Wuhan City : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Xian : Xijing Hospital

A Phase 3 clinical study for patients with NSCLC

Zhengzhou : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Zhengzhou : Henan Provincal Tumor Hospital

A Phase 3 clinical study for patients with NSCLC

Croatia

Zagreb : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Czech Republic

Horovice : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Hradec Kralove : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Olomouc : University Hospital Olomouc, Clinic of Oncology

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Olomouc : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Olomouc : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Ostrava : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Prague : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Prague : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Prague : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Praha 2 : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Usti nad Labem : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Znojmo : Hospital Znojmo, Department of Radiation and Clinical Oncology

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Denmark

Aalborg : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Århus C : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Copenhagen : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Odense : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Finland

Kuopio : Kuopio University Hospital

Patients are needed to participate in a clinical research study evaluating docetaxel and capecitabine for the treatment of Stomach Neoplasms

Oulu : Oulu Univerity Hospital

Patients are needed to participate in a clinical research study evaluating docetaxel and capecitabine for the treatment of Stomach Neoplasms

Tampere : University of Tampere

Patients are needed to participate in a clinical research study evaluating docetaxel and capecitabine for the treatment of Stomach Neoplasms

Turku : Department of Oncology and Radiotherapy, turku University Hospital

Patients are needed to participate in a clinical research study evaluating docetaxel and capecitabine for the treatment of Stomach Neoplasms

Vaasa : Vaasa Distric Hospital

Patients are needed to participate in a clinical research study evaluating docetaxel and capecitabine for the treatment of Stomach Neoplasms

France

Bayonne : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Bordeaux : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Clermont Ferrand Cedex 1 : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Creteil : Hopital Henri Mondor

A clinical trial seeking patients for a research study for the treatment of Adenocarcinoma of Prostate

Creteil : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Dijon cedex : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Grenoble : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Le Mans : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Limoges Cedex : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Lyon Cedex 03 : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Lyon Cedex 08 : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Marseille cedex 5 : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Marseille cedex 5 : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Montpellier Cedex 5 : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Nice cedex 2 : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Périgueux cedex : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Reims : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Rennes : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Saint Priest en Jarez : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Saint Priest en Jarez Cedex : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Strasbourg : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Strasbourg : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Villejuif : Research Site

A clinical trial seeking patients for a research study for the treatment of Renal Cell Adenocarcinoma, Clear Cell Renal Carcinoma, Clear Cell Renal Cell Carcinoma or Renal Cell Carcinoma

Germany

Bad Nauheim : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Berlin : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Berlin : Charité - Universitätsmedizin Berlin Charité Centrum für Tumormedizin

A Phase 1/Phase 2 clinical study for patients with Carcinoma, Pancreatic Ductal

Berlin : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Bielefeld : Onkologische Schwerpunktpraxis Bielefeld

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Bielefeld : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Bochum : Universitätsklinikum Knappschaftskrankenhaus Bochum

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Bochum : Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Brandenburg : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Braunschweig : Prof. Dr. F. Lordick

A clinical research study of catumaxomab, Fluorouracil, leucovorin, oxaliplatin, docetaxel and Fluorouracil, leucovorin, oxaliplatin, docetaxel for the treatment of Gastric Adenocarcinoma With Peritoneal Carcinomatosis, Siewert Type II Adenocarcinoma of Esophagogastric Junction With Peritoneal Carcinomatosis or Siewert Type III Adenocarcinoma of Esophagogastric Junction With Peritoneal Carcinomatosis

Chemnitz : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Cologne : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Cottbus : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Darmstadt : Please Contact Merck Communication Services Located in

A clinical trial seeking patients for a research study for the treatment of Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma

Darmstadt, Germany : Please contact Merck KGaA Communication Center located in

A clinical research study of MEK Inhibitor MSC1936369B, Gemcitabine and Placebo and Gemcitabine and MEK Inhibitor MSC1936369B for the treatment of Pancreatic Adenocarcinoma

Dortmund : Klinikum Dortmund gGmbH Medizinische Klinik Mitte

A Phase 1/Phase 2 clinical study for patients with Carcinoma, Pancreatic Ductal

Dresden : BAG / Onkologische Schwerpunktpraxis

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Dresden : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Dresden : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Elstra : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Essen : Novartis Investigative Site

A clinical research study of LDE225 and BKM120

Essen : Universitätsklinikum Essen, Innere Klinik Tumorforschung

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Essen : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Frankfurt : Institut für Klinische Forschung, Krankenhaus Nordwest GmbH

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Frankfurt am Main : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Freiburg : Universitätsklinikum Freiburg, Innere Medizin II

A Phase 1/Phase 2 clinical study for patients with Carcinoma, Pancreatic Ductal

Freital : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Fürstenwalde : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Gauting : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Grosshansdorf : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Halle/Saale : Universitätsklinikum Halle/Saale; Poliklinik für innere Medizin iV

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Halle/Saale : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Heidelberg : Research Site

A clinical trial seeking patients for a research study for the treatment of Renal Cell Adenocarcinoma, Clear Cell Renal Carcinoma, Clear Cell Renal Cell Carcinoma or Renal Cell Carcinoma

Herne : Medizinische Klinik III - Hämatologie/Onkologie Marienhospital Herne

A Phase 1/Phase 2 clinical study for patients with Carcinoma, Pancreatic Ductal

Kassel : Klinikum Kassel GmbH Medizinischen Klinik IV;Onkologie,

A Phase 1/Phase 2 clinical study for patients with Carcinoma, Pancreatic Ductal

Köthen : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Kronach : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Lebach : Gemeinschaftspraxis für Hämatologie und Onkologie

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Leipzig :

A clinical research study for the treatment of Non-Small Cell Lung Cancer

Leipzig : Universitätsklinikum Leipzig, Klinik und Poliklinik für Gastroenterologie und Rheumatologie

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Leipzig : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Leipzig : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Leipzig : Hospital

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Leubeck : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Magdeburg : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Magdeburg : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Mainz : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Mainz : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Mannheim : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Meiningen : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Mühlhausen : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

München : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

München : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Munich : University of Munich

Patients are needed to participate in a clinical research study for the treatment of Metastatic Pancreatic Adenocarcinoma

Münster : Hämatologisch-Onkologische Gemeinschaftspraxis

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Nürnberg : Klinikum Nürnberg Nord Medizinische Klinik 5

A Phase 1/Phase 2 clinical study for patients with Carcinoma, Pancreatic Ductal

Offenbach : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Oldenburg : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Parchim : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Pinneberg : Onkologische Schwerpunktpraxis Pinneberg

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Plauen : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Regensburg : Klinik und Poliklinik für Innere Medizin I Universitätsklinikum Regensburg

A Phase 1/Phase 2 clinical study for patients with Carcinoma, Pancreatic Ductal

Scheibenberg : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Schweinfurt : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Stuttgart : Klinikum Stuttgart Klinik Hämatologie, Onkologie und Palliativmedizin

A Phase 1/Phase 2 clinical study for patients with Carcinoma, Pancreatic Ductal

Torgau : Clinic

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Ulm : Universitätsklinikum Ulm Zentrum für Innere Medizin

A Phase 1/Phase 2 clinical study for patients with Carcinoma, Pancreatic Ductal

Werdau : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Zittau : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Zwickau : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Greece

Athens : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Athens : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Athens : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Heraklion : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Heraklion : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Larissa : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Nea Kifissia, Athens : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Patra : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Thessaloniki : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Thessaloniki : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Hungary

Budapest : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Budapest : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Budapest : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Budapest : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Deszk : Synta Pharmaceuticals Investigative Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Gyor : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Nyiregyhaza : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Szeged : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Szekesfehervar : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Szolnok : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Indonesia

Jakarta : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Surabaya : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Israel

Haifa : Rambam medical Center

A clinical trial to evaluate treatments using Capecitabine (Xeloda) for patients with Adenocarcinoma Clear Cell

Italy

Ancona : Novartis Investigative Site

A clinical research study of LDE225 and BKM120

Aviano PN : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Brescia : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Catania : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Firenze : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Firenze : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Milano : Novartis Investigative Site

A clinical research study of LDE225 and BKM120

Napoli : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Pisa : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Roma : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Rome : Università Cattolica del Sacro Cuore

Patients are needed to participate in a clinical research study of Spectroscopy device to evaluate Pancreatic Adenocarcinoma

Rozzano MI : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Torino : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Japan

Chuo-ku :

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Fukuoka-shi : Kyushu University

A clinical research study of Tumor markers for the treatment of Pancreatic Adenocarcinoma

Japan : Zeria Investigative sites

A clinical research study of Z-360 and Placebo for the treatment of Metastatic Pancreatic Adenocarcinoma

Kobe :

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Nagoya :

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Osaka-Sayama :

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Korea, Republic of

Busan : Gosin University Gospel Hospital

Patients are needed to participate in a clinical research study of Erlotinib and Silybin-phytosome to evaluate Carcinoma, Non-Small-Cell Lung

Cheongju : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Dong-gu : Ulsan University Hospital

A clinical research study of NOV120101 (Poziotinib) for the treatment of Adenocarcinoma of Lung Stage IIIB or Adenocarcinoma of Lung Stage IV

Gangnam-gu : Samsung Medical Center

A clinical research study of NOV120101 (Poziotinib) for the treatment of Adenocarcinoma of Lung Stage IIIB or Adenocarcinoma of Lung Stage IV

Goyang-si : National Cancer Center

A clinical research study of NOV120101 (Poziotinib) for the treatment of Adenocarcinoma of Lung Stage IIIB or Adenocarcinoma of Lung Stage IV

Goyang-si : National Cancer Center

Patients are needed to participate in a clinical research study evaluating Gefitinib, Placebo and Pemetrexed plusCIsplatin for the treatment of Non Small Cell Lung Cancer or Adenocarcinoma

Jongno-gu : Seoul National University Hospital

A clinical research study of NOV120101 (Poziotinib) for the treatment of Adenocarcinoma of Lung Stage IIIB or Adenocarcinoma of Lung Stage IV

Korea : Zeria Investigative Sites

A clinical research study of Z-360 and Placebo for the treatment of Metastatic Pancreatic Adenocarcinoma

Namdong-Gu : Gachon University Gil Hospital

A clinical research study of NOV120101 (Poziotinib) for the treatment of Adenocarcinoma of Lung Stage IIIB or Adenocarcinoma of Lung Stage IV

Seoul : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Songpa-gu : Asan Medical Center

A clinical research study of NOV120101 (Poziotinib) for the treatment of Adenocarcinoma of Lung Stage IIIB or Adenocarcinoma of Lung Stage IV

Latvia

Daugavpils : Daugavpils Regional Hospital

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Liepaja : Piejuras Hospital, Oncology Clinic

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Riga : Riga East University Hospital, LLC

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Malaysia

Kuala Lumpur : University Malaya Medical Centre

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Kuala Lumpur : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Mexico

Cuernavaca : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Distrito Federal : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Mexico : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Toluca : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Netherlands

Amsterdam : Nederlands Kanker Instituut/Antonie van Leeuwenhoek Ziekenhuis

A clinical research study of Surgical resection

Amsterdam : Academic Medical Center

Patients are needed to participate in a clinical research study to evaluate Barrett'S-associated Dysplasia or Intramucosal Adenocarcinoma

Assen : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Harderwijk : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Maastricht : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Rotterdam : Novartis Investigative Site

A Phase 1 clinical study for patients using LGK974

Utrecht : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Zwolle : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Poland

Bialystok : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Elblag : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Gdansk : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Konin : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Konin : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Krakow : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Lodz : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Olsztyn : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Otwock : Novartis Investigative Site

Patients are needed to participate in a clinical research study of RAD001

Poznan : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Prabuty : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Szczecin : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Warsaw : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Warszawa : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Warszawa : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Portugal

Aveiro : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Guimaraes : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Lisboa : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Porto : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Santa Maria da Feira : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Vila Real : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Romania

Alba Iulia : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Baia Mare : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Brasov : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Bucharest : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Bucharest : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Bucharest : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Bucharest : Novartis Investigative Site

A Phase 2 clinical study for patients with Cachexia

Bucharest : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Bucharest : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Bucharest : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Cluj Napoca : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Cluj Napoca : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Cluj Napoca : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Cluj-Napoca : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Cluj-Napoca : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Cluj-Napoca : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Craiova : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Iasi : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Lasi : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Timisoara : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Russian Federation

Arkhangelsk : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Arkhangelsk : Arkhangelsk Clinical Oncology Center

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Barnaul : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Belgorod : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Birobidzhan : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Bryansk : Bryansk Regional Oncology Center

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Chelyabinsk : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Chelyabinsk : Chelyabinsk Regional Clinical Oncology Center

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Chelyabinsk : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Chita : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Irkutsk : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Ivanovo : Ivanovo Regional Oncology Center

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Ivanovo : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Izhevsk : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Kazan : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Kazan : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Kemerovo : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Khabarovsk : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Khanty-Mansisk : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Krasnodar : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Krasnodar : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Krasnodar : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Krasnoyarsk : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Kursk : Kursk Regional Clinical Oncology Center

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Lipetsk : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Moscow : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Moscow : Blokhin Russian Oncology Research Center

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Moscow : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Novgorod : Regional Clinical Oncology Center

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Novosibirsk : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Obninsk : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Obninsk : Medical Radiology Research Center

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Omsk : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Omsk : Clinical Oncology Center

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Orel : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Orel : Orel Oncology Center

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Orenburg : Orenburg Regional Clinical Oncology Center

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Pyatigorsk : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Pyatigorsk : Pyatigorsk Oncology Center

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Rostov-on-Don : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Ryazan : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Ryazan : Ryazan Regional Clinical Oncology Center

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Saint-Petersburg : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Samara : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Samara : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

St. Petersburg : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

St. Petersburg : First Pavlov State Medical University of St. Petersburg

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

St.Petersburg : St. Petersburg Clinical Hospital

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

St.Petersburg : Nikiforov Russian Center for Emergency and Radiology Medicine

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

St.Petersburg : City Clinical Oncology Center

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Surgut : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Tula : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Ufa : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Velikiy Novgorod : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Vladimir : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Vladivostok : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Volgograd : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Yakutsk : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Yaroslavl : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Yaroslavl : Regional Clinical Oncology Hospital

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Yuzhno-Sakhalinsk : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Serbia

Belgrade :

A clinical trial seeking patients for a research study for the treatment of Non-Small Cell Lung Cancer

Belgrade : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Belgrade : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Belgrade : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Knez Selo :

A clinical trial seeking patients for a research study for the treatment of Non-Small Cell Lung Cancer

Kragujevac : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Nis : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Sremska Kamenica :

A clinical trial seeking patients for a research study for the treatment of Non-Small Cell Lung Cancer

Sremska Kamenica : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Singapore

Singapore :

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Singapore : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Slovakia

Bardejov : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Bratislava : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Poprad : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Trencin : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Slovenia

Golnik : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Ljubljana : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

South Africa

Cape Town : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Groenkloof : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Johannesburg : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Kraaifontein : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Pretoria : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Spain

A Coruña : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Badalona : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Barcelona : Novartis Investigative Site

A clinical research study of LDE225 and BKM120

Barcelona : Novartis Investigative Site

A clinical research study of LDE225 and BKM120

Barcelona : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Barcelona : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Barcelona : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Barcelona : Novartis Investigative Site

A Phase 1 clinical study for patients using LGK974

Barcelona : Hospital Universitario Vall d'Hebron

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Barcelona : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Barcelona : ACROSS

Patients are needed to participate in a clinical research study evaluating bevacizumab for the treatment of Rectal Neoplasms or Locally Advanced Rectal Adenocarcinoma

Elche : Hospital General Universitario de Elche

Patients are needed to participate in a clinical research study of NovoTTF-100L and Gemcitabine to evaluate Pancreatic Adenocarcinoma

Fuenlabrada : Hospital Universitario de Fuenlabrada

Patients are needed to participate in a clinical research study evaluating Arm A chemotherapy and arm B chemotherapy for the treatment of Adenocarcinoma of Colon, Adenocarcinoma of Rectum or Metastatic Disease

La Coruña : Centro Oncológico de Galícia

A clinical trial seeking patients for a research study for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma

L'Hospitalet de Llobregat : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

L'Hospitalet de Llobregat, Barcelona : Institut Català d'Oncologia

A Phase 1 clinical study for patients with Locally Advanced Pancreatic Adenocarcinoma or Metastatic Pancreatic Adenocarcinoma

Madrid : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Madrid : Centro Integral Oncológico Clara Campal

A Phase 1 clinical study for patients with Locally Advanced Pancreatic Adenocarcinoma or Metastatic Pancreatic Adenocarcinoma

Madrid : Hospital Universitario Ramon y Cajal

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Madrid : Centro Integral Oncologico Clara Campal

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Madrid : Hospital Universitario 12 de Octubre

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Madrid : Hospital Madrid Norte Sanchinarro

Patients are needed to participate in a clinical research study evaluating Arm A chemotherapy and arm B chemotherapy for the treatment of Adenocarcinoma of Colon, Adenocarcinoma of Rectum or Metastatic Disease

Madrid : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Madrid : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Madrid : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Madrid : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Madrid : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Madrid : Hospital Universitario Madrid Sanchinarro

Patients are needed to participate in a clinical research study of lurbinectedin (PM01183) and Doxorubicin to evaluate Endometrial Adenocarcinomas, Neuroendocrine Tumors or Small-cell Lung Cancer With Less Than 2 Prior Cytotoxic-containing Lines of Therapy)

Madrid : Hospital 12 de Octubre

Patients are needed to participate in a clinical research study of NovoTTF-100L and Gemcitabine to evaluate Pancreatic Adenocarcinoma

Madrid : Ramon Y Cajal

Patients are needed to participate in a clinical research study of NovoTTF-100L and Gemcitabine to evaluate Pancreatic Adenocarcinoma

Malaga : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Malaga : Hospital Universitario Carlos Haya

Patients are needed to participate in a clinical research study of NovoTTF-100L and Gemcitabine to evaluate Pancreatic Adenocarcinoma

Oviedo : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Pamplona : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Santander : Hospital Universitario Santander

Patients are needed to participate in a clinical research study of NovoTTF-100L and Gemcitabine to evaluate Pancreatic Adenocarcinoma

Sevilla : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Terrassa : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Valencia : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Sweden

Eskilstuna : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Stockholm : Dept. of Oncology-Pathology, Karolinska University Hospital, Solna

A clinical trial to evaluate treatments using AXP107-11 for patients with Adenocarcinoma

Stockholm : Dept. of Clinical Science, Intervention and Technology, Div. of surgery, Karolinska University Hospital, Huddinge

A clinical trial to evaluate treatments using AXP107-11 for patients with Adenocarcinoma

Stockholm : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Switzerland

Bellinzona : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Bern : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Chur : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Zurich : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Taiwan

Kaohsiung : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Tainan : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Taipei :

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Taipei : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Taiwan : Zeria Investigative Sites

A clinical research study of Z-360 and Placebo for the treatment of Metastatic Pancreatic Adenocarcinoma

Thailand

Chiang Mai : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Khon Kaen : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Patumwan Bangkok : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Turkey

Ankara : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Gaziantep : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Istanbul : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Izmir : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Ukraine

Dnipropetrovsk : Dnipropetrovsk City Multispecialty Clinical Hospital #4, Department of Chemotherapy

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Dnipropetrovsk : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Donetsk : Donetsk Regional Antitumor Center, Oncosurgery Department #6D

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Donetsk : Donetsk Regional Antitumor Center, Thoracic Department #2

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Ivano-Frankivsk : Regional Clinical Oncology Center, Department of Abdominal Surgery

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Kharkiv : Kharkiv Regional Clinical Oncology Center, Abdominal Department

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Kharkiv : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Kherson : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Kyiv : Kyiv City Clinical Oncology Center, Department of Chemotherapy

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Kyiv : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Lutsk : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Lviv : Lviv State Regional Treatment and Diagnostics Oncology Center, Department of Chemotherapy

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Lviv : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Mariupol : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Poltava : Poltava Regional Clinical Oncology Center, Thoracic Department

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Simferopol : Clinical Diagnostics Center, LLC, Treatment and Diagnostics Center, Department of Oncology

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Sumy : Sumy Regional Clinical Oncology Center, Oncothoracic Department

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Sumy : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Uzhgorod : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Uzhhorod : Zakarpattia Regional Clinical Oncology Center, Department of Chemotherapy

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Zaporizhia : Zaporizhia Regional Clinical Oncology Center, Department of Surgery (Abdominal)

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

United Kingdom

Belfast : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Cardiff : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Edinburgh : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Edinburgh : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Glasgow : Novartis Investigative Site

A clinical research study of LDE225 and BKM120

Guildford : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Leicester : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Leicester : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

London : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

London : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

London : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

London : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

London : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

London : UCLH (University College London Hospitals)

Patients are needed to participate in a clinical research study of lurbinectedin (PM01183) and Doxorubicin to evaluate Endometrial Adenocarcinomas, Neuroendocrine Tumors or Small-cell Lung Cancer With Less Than 2 Prior Cytotoxic-containing Lines of Therapy)

Manchester : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Newcastle Upon Tyne : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Northwood : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Nottingham : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Nottingham : Nottingham Univeristy Hospitals NHS Trust

Patients are needed to participate in a clinical research study evaluating Iron isomaltoside 1000 for the treatment of Anemia, Esophageal Cancer or Gastric Cancer

Salisbury : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Southampton : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Sutton : Novartis Investigative Site

A clinical research study of LDE225 and BKM120

Sutton : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Sutton : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

 

Kidney & Urology Foundation of America | 152 Madison Ave, Suite 201 | New York, NY 10016 | 1.800.633.6628
©

About Us | Patient Resources | Professional Resources | Support Us | News & Recent Events | Brochures
Corporate Sponsors | Contact Us | Terms of Use | Privacy Policy

Website Last Modified: October 28, 2010
Donate Today Donate Your Car Join KUFA Now